Registres
Chaque registre avec son nombre de médicaments et quelques-uns d’entre eux.
États-Unis
FDA · 18 médicaments
- Adderall XR 102.5MG; 2.5MG; 2.5MG; 2.5MG · capsule, extended release · Takeda Pharms USA
- Adderall XR 153.75MG; 3.75MG; 3.75MG; 3.75MG · capsule, extended release · Takeda Pharms USA
- Adderall XR 205MG; 5MG; 5MG; 5MG · capsule, extended release · Takeda Pharms USA
- Adderall XR 256.25MG; 6.25MG; 6.25MG; 6.25MG · capsule, extended release · Takeda Pharms USA
Tous les médicaments contenant Amphetamine aspartate
Tous les registres, page par page. Dosages et conditionnements figurent sur la page de chaque médicament.
27 résultats
| Médicament | Registre | Dosage | Forme | Statut | Titulaire |
|---|---|---|---|---|---|
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 1.875MG; 1.875MG; 1.875MG; 1.875MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | tablet | Commercialisé | Actavis Elizabeth |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 12.5MG; 12.5MG; 12.5MG; 12.5MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | capsule, extended release | Commercialisé | Ani Pharms |
| Adderall XR 5Association | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 10Association | États-Unis | 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 15Association | États-Unis | 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 20Association | États-Unis | 5MG; 5MG; 5MG; 5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 25Association | États-Unis | 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 30Association | États-Unis | 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Dextroamp Saccharate,Amp Aspartate,Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG, 3.75MG; 3.75MG; 3.75MG; 3.75MG … | capsule, extended release | Non commercialisé | Barr Labs INC |
| MydayisAssociation | États-Unis | 12.5MG; 12.5MG; 12.5MG; 12.5MG, 3.125MG; 3.125MG; 3.125MG; 3.125MG, 6.25MG; 6.25MG; 6.25MG; 6.25MG … | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall 5Association | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 10Association | États-Unis | 2.5MG; 2.5MG; 2.5MG; 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 15Association | États-Unis | 3.75MG; 3.75MG; 3.75MG; 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 20Association | États-Unis | 5MG; 5MG; 5MG; 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 30Association | États-Unis | 7.5MG; 7.5MG; 7.5MG; 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 7.5Association | États-Unis | 1.875MG; 1.875MG; 1.875MG; 1.875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 12.5Association | États-Unis | 3.125MG; 3.125MG; 3.125MG; 3.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Dextroamphetamine Saccharate; Amphetamine Aspartate Monohydrate; Dextroamphetamine Sulfate; Amphetamine SulfateAssociation | États-Unis | 10MG, 15MG, 20MG … | capsule, extended release | Approbation provisoire | Corepharma |
| Amphetamine | États-Unis | 12.5MG BASE, 15.7MG BASE, 18.8MG BASE … | tablet, orally disintegrating, extended release | Commercialisé | Actavis Labs FL INC |
| Amphetamine Sulfate | États-Unis | 10MG, 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG … | tablet | Commercialisé | Granules |
| Dyanavel XRAssociation | États-Unis | 2MG/ML; 0.5MG BASE/ML | suspension, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 10Association | États-Unis | 8MG; 2MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 15Association | États-Unis | 12MG; 3MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 20Association | États-Unis | 16MG; 4MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 5Association | États-Unis | 4MG; 1MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
Noms de marque
La même marque dans plusieurs registres.
Laboratoires
Les laboratoires titulaires de ses médicaments, les plus importants d’abord.
Souvent associée à
Les substances avec lesquelles elle partage un médicament.
Sources
Compilé par Prognia à partir des registres publics du médicament de FDA. La page de chaque médicament indique sa propre source, sa licence et son attribution.
Signaler une erreur ou demander un retraitLes corrections d’un registre ou d’un laboratoire sont les bienvenues.
Pour la consultation et l’apprentissage, pas un avis thérapeutique. Vérifiez toujours l’information officielle du produit.
En bref
- Registres
- 1
- Médicaments
- 18
- Laboratoires
- 6